Katie Jennings is a senior writer at Forbes covering healthcare, technology and AI and a co-author of the InnovationRX newsletter. She joined Forbes in 2020 and is based in Jersey City.
Rock Health's half year 2024 report suggests there's a light at the end of the tunnel for healthcare VC funding.raised $5.7B across 266 deals in the first half of 2024. And, if these trends persist, this year could be on track to meet or exceed 2019 and 2023 funding levels–getting back to “normal” after the pandemic-fueled peak.AI, duh! But how do you separate reality from hype? For starters, don’t lead your pitch with “we are an AI company.
With its DNA sequencing platform Aviti, San Diego-based startup Element Biosciences is among the many players in this R&D sandbox. On Thursday, the company announced that it has raised a $277 million series D investment at a $1.03 billion valuation. It's a well-timed boon for Element.raised $74 million co-led by Wittington Ventures and Great Point Ventures. The funding will go towards clinical trials as the company seeks FDA approval for the device.
Our community is about connecting people through open and thoughtful conversations. We want our readers to share their views and exchange ideas and facts in a safe space.Insults, profanity, incoherent, obscene or inflammatory language or threats of any kindContinuous attempts to re-post comments that have been previously moderated/rejectedAttempts or tactics that put the site security at riskProtect your community.
Wegovy Ozempic Cancer Eli Lilly Venture Capital Healthcare
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
An Unseen State Of Emergency In Healthcare: Lessons From The Change Healthcare Cyber BreachCamellia Chan is the CEO and Cofounder of Flexxon, a next-generation hardware cybersecurity solutions provider with a global presence. Read Camellia Chan's full executive profile here.
Read more »
InnovationRx: The FTC Is Going After Pharmacy MiddlemenAlex Knapp is a senior editor covering healthcare, science, and cutting edge technology who joined Forbes in 2011. He's written dozens of profiles of entrepreneurs across a variety of fields and done deep dives into technological trends from superconductors to space travel to pharmaceuticals.
Read more »
InnovationRx: The FTC Is Going After Pharmacy MiddlemenAlex Knapp is a senior editor covering healthcare, science, and cutting edge technology who joined Forbes in 2011. He's written dozens of profiles of entrepreneurs across a variety of fields and done deep dives into technological trends from superconductors to space travel to pharmaceuticals.
Read more »
InnovationRx: The FTC Is Going After Pharmacy MiddlemenAlex Knapp is a senior editor covering healthcare, science, and cutting edge technology who joined Forbes in 2011. He's written dozens of profiles of entrepreneurs across a variety of fields and done deep dives into technological trends from superconductors to space travel to pharmaceuticals.
Read more »
InnovationRx: A Fourth Dairy Worker Has Contracted Avian FluKatie Jennings is a senior writer at Forbes covering healthcare, technology and AI and a co-author of the InnovationRX newsletter. She joined Forbes in 2020 and is based in Jersey City.
Read more »
InnovationRx: Oracle Debuts AI Tool To Cut Doctor’s Screen Time By 50%Katie Jennings is a senior writer at Forbes covering healthcare, technology and AI and a co-author of the InnovationRX newsletter. She joined Forbes in 2020 and is based in Jersey City.
Read more »